Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-fucose in GLUT1 Deficiency Syndrome
NCT07432490Phase 2Recruiting
- Sponsor
- Oregon Health & Science University
- Start
- May 2026
- Primary completion
- Jul 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of AUG-803 in Glucose transporter type 1 deficiency syndrome (GLUT1DS), sponsored by Oregon Health & Science University. Started May 2026; status: recruiting.
02
Drugs
AUG-803
03
Conditions
Glucose transporter type 1 deficiency syndrome (GLUT1DS)
Beyond the preview
Go deeper on NCT07432490.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07432490.